化妝品填充劑市場：按產品類型、材料類型、應用、地區 - 規模、份額、展望、機會分析2022-2028

美容填充劑近年來迅速普及，因為它們提供以前只能通過手術才能實現的年輕化和美學改善。真皮填充劑、唇部和麵部填充劑、皺紋填充劑或軟組織填充劑均已獲得 FDA 批准，可打造更光滑、更飽滿的面部外觀。由於消費者對美容的關注度越來越高，對外觀的興趣也越來越大，注射美容的需求量逐年增加。

市場動態。

化妝品填充劑需求的增長、對面部美學的日益關注、整容手術數量的增加以及老年人口的增加是預計在預測期內推動全球化妝品填充劑市場增長的主要因素。

2022 年 8 月，艾伯維旗下公司 Allergan Aesthetics 獲得美國食品和藥物管理局 (FDA) 的批准，宣布 JUVEDERM VOLUX XC 用於改善 21 歲及以上成年人的中度至重度下巴減少。

2022 年 2 月，Merz Aesthetics 進行深層注射（皮下和/或骨膜上）軟組織填充，以改善 21 歲及以上成年人中度至重度下頜輪廓缺失，宣布推出 Radiesse(+) 利多卡因注射植入物。

這項研究的主要特點

• 本報告對化妝品填料市場進行了深入分析，提供了以 2021 年為基準年的預測期 (2022-2028) 的市場規模和復合年增長率 (CAGR%)。
• 它還揭示了各個細分市場的潛在收入機會，並描述了一個有吸引力的市場投資建議矩陣。
• 它還提供了有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景、主要參與者採用的競爭戰略等方面的重要見解。
• 公司簡介根據以下參數展示了全球化妝品填料市場的領先企業，包括公司亮點、產品組合、主要亮點、業績和戰略。
• 參與這項研究的主要公司包括 Teoxane Laboratories、Suneva Medical Inc.、Sinclair Pharma、Merz Pharma、Vital Esthetique、Galderma Pharma SA、Laboratories Vivacy SAS 和 Allergan PLC (Abbvie Inc.) 等。
• 這份報告中的見解將使營銷人員和企業高管能夠就他們未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。將是
• 本報告針對行業中的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球化妝品填料市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 按產品類型劃分的市場概況
  • 按材料類型分類的市場概況
  • 市場概況：按應用分類
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 整形手術的增加
  • 與美容填充劑相關的副作用
  • 全球對面部美容的需求增加
• 影響分析
• 主要亮點
• 監管情景
• 產品發布和批准
• 害蟲分析
• 對 PORTER 的分析
• 合併/收購場景

第 4 章全球化妝品填料市場-冠狀病毒 (COVID-19) 大流行的影響

• COVID-19 的流行病學
• 供應方和需求方分析
• 經濟影響

第 5 章全球化妝品填料市場：按產品類型，2017-2028

• 吸收性
• 不可吸收

第 6 章全球化妝品填料市場：按材料類型分類，2017-2028

• 聚合物和顆粒
• 膠原蛋白
• 透明質酸

第 7 章：全球化妝品填料市場，按應用，2017-2028

• 面部線條矯正和皺紋
• 整容
• 唇部護理
• 其他用途

第 8 章全球化妝品填料市場，按地區劃分，2017-2028

• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲
• 世界其他地方

第9章競爭格局

• Teoxane Laboratories
• Suneva Medical Inc.
• Sinclair Pharma
• Merz Pharma
• Laboratories Vivacy SAS
• Vital Esthetique
• Galderma Pharma SA
• Allergan PLC（Abbvie Inc.）

第 10 章

• 調查方法介紹
• 關於出版商

The popularity of aesthetic fillers has grown rapidly in recent years as they provide rejuvenating and enhancing aesthetic improvements that previously could only be achieved with surgery. Dermal fillers, lip and facial fillers, wrinkle fillers, or soft tissue fillers are approved by FDA to create a smoother and/or fuller appearance in the face. The demand for aesthetic injectable has increased over the years as a result of customers' increasing emphasis on beauty or increase in focus on the physical appearance.

Market Dynamics:

Increasing demand for aesthetics fillers, increase in attention on facial aesthetics, rise in number of cosmetic procedures, and growing geriatric population are major factors expected to propel the growth of the global aesthetic fillers market over the forecast period.

In August 2022, Allergan Aesthetics, an AbbVie company announced the U.S. Food and Drug Administration (FDA) approval of JUVEDERM VOLUX XC for the improvement of jawline definition in adults over the age of 21 with moderate to a severe loss of jawline definition.

In February 2022, Merz Aesthetics announced the launch of Radiesse (+) Lidocaine injectable implant for deep injection (subdermal and/or supraperiosteal) for soft tissue augmentation to improve moderate to a severe loss of jawline contour in adults over the age of 21.

Key features of the study:

• This report provides in-depth analysis of the aesthetic fillers market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022-2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global aesthetic fillers market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Teoxane Laboratories, Suneva Medical Inc., Sinclair Pharma, Merz Pharma, Vital Esthetique, Galderma Pharma SA, Laboratories Vivacy SAS, and Allergan PLC (Abbvie Inc.), among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global aesthetic fillers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aesthetic fillers market.

Detailed Segmentation:

• Global Aesthetic Fillers Market, By Product Type:
  • Absorbable
  • Non-absorbable
• Global Aesthetic Fillers Market, By Material Type:
  • Polymers and Particles
  • Collagen
  • Hyaluronic Acid
• Global Aesthetic Fillers Market, By Application:
  • Facial Line Correction and Wrinkles
  • Face Lift
  • Lip Treatment
  • Other Applications
• Global Aesthetic Fillers Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Teoxane Laboratories
  • Suneva Medical Inc.
  • Sinclair Pharma
  • Merz Pharma
  • Laboratories Vivacy SAS
  • Vital Esthetique
  • Galderma Pharma SA
  • Allergan PLC (Abbvie Inc.)

Table of Contents:

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Material Type
  • Market Snapshot, By Application
  • Market Snapshot, By Geography
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Increase in the number of cosmetic procedures
  • Side effects associated with aesthetic fillers
  • Increasing demand for facial aesthetics worldwide
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Aesthetic Fillers Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Aesthetic Fillers Market, By Product Type, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Absorbable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Non-absorbable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

6. Global Aesthetic Fillers Market, By Material Type, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Polymers and Particles
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Collagen
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Hyaluronic Acid
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

7. Global Aesthetic Fillers Market, By Application, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• Facial Line Correction and Wrinkles
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Face Lift
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Lip Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)
• Other Applications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2028,(US$ Mn)

8. Global Aesthetic Fillers Market, By Geography, 2017-2028, (US$ Mn)

• Introduction
  • Market Share Analysis, 2022 and 2028 (%)
  • Y-o-Y Growth Analysis, 2017 - 2028
  • Segment Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Middle East and Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)
• Rest of World
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017-2028,(US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2028,(US$ Mn)

9. Competitive Landscape

• Teoxane Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Suneva Medical Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sinclair Pharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merz Pharma
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Laboratories Vivacy SAS
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Vital Esthetique
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Galderma Pharma SA
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Allergan PLC (Abbvie Inc.)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us